Regulation 2 Amendment to regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013
Regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (zero or nominal product reimbursement for vaccines and antivirals)f1 is amended as follows.
In paragraph (2)—
omit “or” at the end of sub-paragraph (ae); and
after sub-paragraph (ae), insert—
“(af)a drug or medicine which is used for vaccinating or immunising people against meningococcal disease caused by—
(i)Neisseria meningitidis groups A, C, W and Y bacteria, or
(ii)Neisseria meningitidis group B bacteria,
if the conditions set out in paragraph (3) are satisfied;
(ag)a drug or medicine which is used for vaccinating or immunising people against tetanus, diphtheria and polio, if the conditions set out in paragraph (3) are satisfied; or”.
In paragraph (3A), for “to (ae)” substitute “to (ag)”.
Annotations
Footnotes
- f1
-
Inserted by S.I. 2022/930. Relevant amending instruments are S.I. 2024/838, 2024/894, 2025/636 and 2025/989.